Levetiracetam Brand Indication Dosage Form Cost/Packing: Adult and Adolescent 16 Years 500mg BID
This document summarizes information on 5 brands of the anti-epileptic drug levetiracetam. It provides the brand name, indication, dosage forms, dosing recommendations and cost for each. The dosages vary depending on the condition being treated, whether used as monotherapy or add-on therapy, and patient age and weight. All require gradual titration to the maximum recommended daily dose to improve tolerability.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
327 views
Levetiracetam Brand Indication Dosage Form Cost/Packing: Adult and Adolescent 16 Years 500mg BID
This document summarizes information on 5 brands of the anti-epileptic drug levetiracetam. It provides the brand name, indication, dosage forms, dosing recommendations and cost for each. The dosages vary depending on the condition being treated, whether used as monotherapy or add-on therapy, and patient age and weight. All require gradual titration to the maximum recommended daily dose to improve tolerability.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 4
LEVETIRACETAM
BRAND INDICATION DOSAGE FORM COST/PACKING
1. Ivetra (Torrent) Adjunctive therapy in the treatment of partial seizures with or without secondary generalization Adult and adolescent >16 years 500mg BID, may be increased to 1500mg BID. Dose titration can be made in 500mg increments or decrements.
Elderly and patients with renal impairment individualized dosage 1000 film-coated tablet 1000mg
250 film-coated tablet 250mg
500 film-coated tablet 500mg 60s (P4945.50/pack)
60s (P1283.78/pack)
60s (P2538.27/pack) 2. Letram (Hetero drugs) Adjunctive therapy in the treatment of partial seizures with or without secondary generalization Monotherapy adult and adolescent >16 years initially 250mg BID increased to 500mg BID after 2weeks. May be further increased by 250mg BID twice weekly. Max: 1500mg BID
ADD-ON THERAPY adult and adolescent >12 years >50kg initially 500mg BID, may be increased up to 1500mg BID. Dose may be titrated by increment/ decrement of 500mg BID 2-4 times weekly.
4-17 years <50kg initially 10mg/kg BID, may be 250mg film- coated tablet
500mg film- coated tablet 100s
100s increased up to 30mg/kg BID. Dose increment/decrement should not exceed 10mg/kg BID 2x weekly.
Children >50kg adult dose 3. Vexlev (VE Pharma) Adjunct in the treatment of partial seizures with or without secondary generalizations Adult >16 years 250mg, increase in increments of 500mg every 2weeks. Max: 1500mg.
Pedia (20kg body weight) 4-16 years 10mg/kg, increased increments of 10mg/kg every 2 weeks to 30mg/kg; 6months- 4years 10mg/kg, increased increments of 10mg/kg every 2weeks to 25mg/kg; 1 to <6 months 7mg/kg, increased increments of 7mg/kg every 2weeks to 21mg/kg.
Myoclonic seizures adult and ped >12 years 500mg, increased by 500mg every 2weeks to 1500mg.
250mg film- coated tablet
500mg film- coated tablet 30s
30s Primary generalized tonic-clonic seizures adult >16 years 500mg, increased by 500mg every 2weeks to 1500mg; Pedia 6-16 years 10mg/kg, increase in increments of 10mg/kg every 2weeks to 30mg/kg. All doses to be taken BID 4. Keppra (GlaxoSmithKline) Monotherapy in the treatment of partial onset seizures with or without secondary generalization in patients > 16 years with newly diagnosed epilepsy.
Adjunctive therapy in the treatment of partial seizures with or without secondary generalizations in adults and children >4 years with epilepsy
Myoclonic seizures in adults and adolescents >12 years with juvenile myoclonic epilepsy
Primary generalized tonic- clonic seizures in adults and children >4 years with idiopathic generalized Monotherapy adult and adolescent >16 years initially 250mg BID, increased to 500mg BID after 2 weeks. May be further increased by 250mg BID 2x weekly. Max: 1500mg BID.
Add on therapy adult (>18 years) & adolescent 12-17 yrs >50kg initially 500mg BID, may b increased up to 1500mg BID. Dose may be titrated by increment/decrement of 500mg BID 2-4x weekly.
Children and adolescent >50kg adult dose; 4- 17yrs <50kg initially 10mg/kg BID, may be 1000mg film- coated tablet
250mg film- coated tablet
500mg film- coated tablet
500mg/5mL infusion concentration
100mg/mL oral solution 60s (P7187.00/pack)
60s (P1977.00/pack)
60s (P3952.00/pack)
Vial x 5mL x 5 x 1s (P30477.70/box)
300mL x 1s (P1927.80/bottle) epilepsy increased up to 30mg/kg BID. Dose increment/decrement should not be >10mg/kg BID 2x weekly; children <25kg start the treatment with 100mg/mL oral solution. 5. Levit (InnoGen Pharmaceuticals) Adjunctive therapy in the treatment of partial seizures with or without secondary generalization
Second-line drug in generalized tonic clonic seizures, myoclonus including juvenile myoclonic epilepsy and atonic or tonic seizures Initially 1g on day 1 in 2 divided doses. May be increased in increments of 1g every 2-4 weeks up to max of 3g daily. 1g film-coated tablet